Transce3nd’s Eastman Chemical EMN Stock Holding History

Transce3nd’s Portfolio EMN Stock Details EMN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-12	Closed	-$896	–	441
2025 Q2	$896	Buy	+12	New	+$943	﹤0.01%	1004

Other funds holding EMN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Transce3nd's EMN Position: Q3 2025 in Review

Transce3nd sold out of Eastman Chemical (EMN) in Q3 2025, closing a stake of 12 shares — an estimated $896 sold.

Transce3nd first reported a position in EMN in Q2 2025 and held it in 1 quarter. The position peaked at $896 in Q2 2025. 663 funds tracked by Wall St. Rank hold EMN as of Q3 2025.

Transce3nd reported no remaining Eastman Chemical position as of Q3 2025 after selling out during the quarter.
Transce3nd sold 12 Eastman Chemical shares in Q3 2025, an estimated $896.
Transce3nd first reported a position in Eastman Chemical in Q2 2025 and held it in 1 quarter.
Transce3nd's Eastman Chemical position peaked at $896 in Q2 2025.
663 funds tracked by Wall St. Rank held Eastman Chemical as of Q3 2025.

Based on Transce3nd's 13F filing for Q3 2025, filed 12 Nov 2025.